Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Mobile technology has the ability to transform virtually every line of business.
January 28, 2016
By: Mika Javanainen
M-Files Corporation
Many pharmaceutical companies are now on the path towards a full throttle mobile transformation. Smartphones and tablets are standard equipment for sales forces, automating everything from new hire training and field visit preparation with physicians, to travel route planning and more. Mobile apps are also offering employees a more convenient way to access documentation and business processes. What pharmaceutical firms are finding is that mobile technology has the ability to transform virtually every line of business—from manufacturing and research to sales, distribution and customer service. But, as these companies embrace mobile strategies to improve productivity, cut costs and support product innovation, they must also shore up the potential vulnerabilities that can be exposed from the improper and unregulated use of this technology. How can pharmaceutical companies capitalize on the benefits of going mobile without compromising regulatory compliance and quality management practices? What protections should be put in place when priming for the mobile enterprise? Quality and Compliance Considerations When Going Mobile Pharmaceutical companies must remain vigilant in ensuring the ongoing integrity of their quality and compliance practices when evaluating mobile strategies, particularly those that involve the management of core content assets. The use of enterprise information management (EIM) systems with native mobile apps has become more pervasive since these solutions enable employees to easily manage, share and process information they’re authorized to access from anywhere at any time, whether online or offline. More importantly, unlike most enterprise file sync and share solutions, modern EIM mobile apps can enable convenient mobile access to content without compromising EU or FDA regulatory requirements. As the use of mobile devices and apps continues to become increasingly mainstream for pharmaceutical businesses, the following quality and compliance-related issues should be carefully considered: Compliant Workflows with eSignatures Electronic signatures stand at the center of the FDA’s 21 CFR Part 11 regulation. Making electronic signatures executable from the field via mobile devices can eliminate business bottlenecks, create added efficiencies, and support employees for whom mobile devices represent their primary method of communication. For example, if R&D updates a drug-related SOP, a notification can be instantly triggered to alert the clinical research team. As a result, lab technicians in the field can use their mobile devices or tablets to review the updated policy and attest that they have read and understood the new policy by providing electronic signature verification. With an EIM system driving and automating these information processes, the result is streamlined lab and drug manufacturing workflows and improved efficiencies. Managing Risks and Deviations Mobile apps can help pharmaceutical workers capture risks and deviations on-site immediately as they occur. Cameras in mobile devices can be used to capture photographic evidence of issues, therefore expediting their resolution. Observing issues proactively leads to fewer deviations and issues, and mitigates risks before deviations occur—offering businesses a more efficient and cost effective method for problem identification and resolution. Trusted Audit Trails Pharmaceutical businesses were early adopters of enterprise content management (ECM) and EIM solutions. As a result, many EIM solutions can furnish a full audit log on all information assets managed, tracked and processed within the system. When mobile applications are fully integrated with the core solution, the activities performed by mobile users are also tracked and can be provided as evidence during audits. Many EIM platforms can organize and manage all enterprise compliance-related documents and associated processes with complete version history, automatic permissions and workflow steps. Mobile devices give users the power to access, manage, share and process information at their fingertips, enhancing the speed and accuracy of business operations. As pharmaceutical companies embrace mobile enablement, they must be mindful to deploy solutions that safeguard compliance-related documents and processes, leveraging the benefits of going mobile while mitigating the risks.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !